PFM Health Sciences’s MeiraGTx Holdings MGTX Stock Holding History

PFM Health Sciences’s Portfolio MGTX Stock Details MGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.15M	Buy	+455,286	New	+$4.52M	0.53%	61

Other funds holding MGTX

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

PFM Health Sciences's MGTX Position: Q2 2026 in Review

PFM Health Sciences opened a new position in MeiraGTx Holdings (MGTX) in Q2 2026: 455,286 shares worth $6.15M. The stake represents 0.53% of the portfolio and ranks #61 among its holdings.

158 funds tracked by Wall St. Rank hold MGTX as of Q2 2026.

PFM Health Sciences held 455,286 shares of MeiraGTx Holdings worth $6.15M as of Q2 2026.
MeiraGTx Holdings was a new PFM Health Sciences position in Q2 2026.
MeiraGTx Holdings made up 0.53% of PFM Health Sciences's portfolio in Q2 2026, its #61 holding.
158 funds tracked by Wall St. Rank held MeiraGTx Holdings as of Q2 2026.

Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.